Catalogue Number
CT694-H
Description
mAb anti-human/mouse IL-5 (TRFK5) - 0.5 mg
Price
€ 280.00
Characteristics
clone TRFK5
Summary
The rat anti-human IL-5 monoclonal antibody (clone TRFK5) was first described in 1988. The TRFK5 antibody recognizes and neutralizes both human and mouse IL-5 (Schumacher J.H. et al. 1988). The antibody has been descriped as useful in a sandwich ELISA (Schumacher J.H. et al. 1988) and the ELISPOT assay (Taguchi T. et al. 1990). The TRFK5 antibody has also been reported for use in intracellular staining (Belkaid Y. et al. 1998), immunohistochemical staining (Fan W.Y. et al. 2001) and Western Blot (Zhang J. et al. 1999).
References list
- Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis.
- Effects of dietary restriction on spontaneous dermatitis in NC/Nga mice.
- The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent.
- Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay.
- Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5.